Annualized recurring revenue (“ARR”) of $838 million, an increase of 2% year-over-yearTotal revenue of $218 million, up 2% year-over-year; ...
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, ...
Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback